Triple
T10837777
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Bruton tyrosine kinase |
E255805
|
entity |
| Predicate | hasAlternativeName |
P39
|
FINISHED |
| Object | BTK tyrosine kinase |
E561038
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: BTK tyrosine kinase | Statement: [Bruton tyrosine kinase, hasAlternativeName, BTK tyrosine kinase]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: BTK tyrosine kinase Context triple: [Bruton tyrosine kinase, hasAlternativeName, BTK tyrosine kinase]
-
A.
Bruton tyrosine kinase
Bruton tyrosine kinase is a key signaling enzyme in B cells that plays a crucial role in their development and function and is a major therapeutic target in certain blood cancers and autoimmune diseases.
-
B.
BTK
chosen
BTK (Bruton’s tyrosine kinase) is a key signaling enzyme in B cells and a major therapeutic target in certain blood cancers and autoimmune diseases.
-
C.
CD20 protein
CD20 protein is a cell-surface antigen found primarily on B lymphocytes and is a key therapeutic target in certain autoimmune diseases and B-cell malignancies.
-
D.
CDK6
CDK6 is a cyclin-dependent kinase that regulates cell cycle progression and is a key target in certain cancer therapies.
-
E.
PLCγ2
PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aa81a5d08190aa86689061d1ddd2 |
completed | April 8, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69d747002b3081908726901ee83d8f38 |
completed | April 9, 2026, 6:28 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69dff7c739708190b0d58fc2d6392c6c |
completed | April 15, 2026, 8:40 p.m. |
Created at: April 8, 2026, 9:19 p.m.